SRD5A2 c.278+23410T>C

Variant ID: 2-31782280-A-G

NM_000348.4(SRD5A2):c.278+23410T>C

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus.

The Journal Of Infectious Diseases
Cindi, Zinhle Z; Kawuma, Aida N AN; Maartens, Gary G; Bradford, Yuki Y; Venter, Francois F; Sokhela, Simiso S; Chandiwana, Nomathemba N; Wasmann, Roeland E RE; Denti, Paolo P; Wiesner, Lubbe L; Ritchie, Marylyn D MD; Haas, David W DW; Sinxadi, Phumla P
Publication Date: 2022-11-01

Variant appearance in text: rs2268796
PubMed Link: 35512135
Variant Present in the following documents:
  • EMS145648-supplement-Supplementary_file.pdf
View BVdb publication page



The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population.

Korean Journal Of Urology
Choi, Se Young SY; Kim, Hae Jong HJ; Cheong, Hyun Sub HS; Myung, Soon Chul SC
Publication Date: 2015-01

Variant appearance in text: rs2268796
PubMed Link: 25598933
Variant Present in the following documents:
  • kju-56-19-s001.pdf
  • kju-56-19.pdf
View BVdb publication page